Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine + dexmedetomidine versus ropivacaine + fentanyl for acute post-cesarean pain
IRCT20191026045246N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Feb 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of ropivacaine, dexmedetomidine and fentanyl in postoperative pain (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: Reduction of acute pain after cesarean section and Ropivacaine fentanyl dexamethidine. Started Feb 2020; status: completed.
02
Drugs
ropivacainedexmedetomidinefentanyl
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20191026045246N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191026045246N1.